Globus Medical (GMED) Reports In-Line Q3 EPS, Beats on Revenues; Reaffirms FY17 EPS/Revenue Guidance

Go back to Globus Medical (GMED) Reports In-Line Q3 EPS, Beats on Revenues; Reaffirms FY17 EPS/Revenue Guidance
GLOBUS MEDICAL, Inc. (NYSE: GMED) Delayed: 78.05 -4.86 (5.86%)
Previous Close $82.91    52 Week High $28.60 
Open $80.80    52 Week Low $19.25 
Day High $80.84    P/E 106.92 
Day Low $77.77    EPS $0.73 
Volume 1,676,978